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Abstract
Dengue virus (DENV) infects humans through the skin. The early infection and encoun‐
ters between DENV and cutaneous immune and non‐immune cells only recently are 
under investigation. We have reported DENV‐infected cutaneous dendritic cells (DCs), 
also keratinocytes and dermal fibroblasts permissive to DENV infection. Now, upon cuta‐
neously inoculating fluorescently labeled DENV into immune‐competent mice, we found 
DENV mostly in dermis from 1 h post‐inoculation. Afterwards, DENV rapidly localized 
in the subcapsular sinus of draining lymph nodes (DLNs) associated with CD169+ mac‐
rophages, suggesting virus travelling through lymph flow. However, DENV association 
with CD11c+ DCs in the paracortex and T:B border suggests DENV being ferried from 
the skin to DLNs by DCs too. DENV was not associated with F4/80+ macrophages nor 
with DEC205+ DCs, but it was inside B cell follicles early after cutaneous inoculation. 
DENV inside B follicles likely affects the development of humoral responses. Antibody 
responses deserve very careful scrutiny as neutralizing memory antibodies are crucial to 
counteract homotypic reinfections whereas non‐neutralizing ones might facilitate hetero‐
typic DENV infection or even Zika infection, another flavivirus. Unravelling the DENV 
journey from skin to lymph into regional nodes and the cellular compartments will aid to 
understand the disease, its pathology and how to counteract it.
Keywords: dengue virus, skin, lymph nodes, immune tissues, macrophages, dendritic 
cells, B cell follicles
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1. Introduction
Dengue virus (DENV) is an important viral pathogen affecting every year almost 400 million 
people worldwide [1]. Over the past 50 years, the incidence of dengue has increased 30‐fold 
mainly in tropical and subtropical areas causing serious public health problems [2]. DENV 
triggers a diversity of clinical manifestations, from an asymptomatic infection in the  majority 
of cases, to a mild febrile illness or a life‐threatening hemorrhagic disease such as severe den‐
gue (SD) or dengue shock syndrome (DSS) [3].
DENV is transmitted to humans when a priorly infected Aedes aegypti female mosquito bites 
to take a ~4.2 µl blood meal by probing around 141 s in the skin of a healthy person [4, 5]. 
By the time that half‐length (~0.9 mm) of the proboscis is inserted, around 50,000 DENV 
plaque‐forming units are deposited in the dermis, where a variety of resident immune and 
non‐immune cells are located, including dermal dendritic cells (DCs), macrophages (Mfs), 
T lymphocytes, mast cells, keratinocytes, fibroblasts, etc., as well as lymphatic and blood ves‐
sels through which migrating cells travel to lymph nodes (LNs) and arrive at the skin [6–9].
While the regional (cutaneous) responses to DENV entrance are recently under intense scru‐
tiny [10–14], less much is known about how exactly DENV gets its way into lymphatic ves‐
sels, secondary lymphoid tissues (if at all) and to which cells might be associated in each of 
these compartments. By infecting immune‐competent mice through the skin, we recently 
demonstrated not only a strong germinal center (GC) reaction in the draining lymph nodes 
(DLNs) but also the presence of viral proteins inside these organs [13]. Others have also 
reported viral proteins inside LNs (NS1, NS3, PrM and E protein) both in humans and mice, 
suggesting that at least the interactions of viral antigens (Ags) with LN‐immune cells are 
taking place [13, 15, 16].
There is scarce information of the early events happening in the skin during DENV entrance. 
Some authors have reported an immunomodulatory environment by the mosquito saliva 
[17, 18], for instance, downregulation of antiviral molecules such as interferon β (IFN‐β), 
IFN‐γ, some pattern recognition receptors, or even sustained viremia, among others, helping 
to establish the infection [19, 20]. It has also been demonstrated a productive infection of fibro‐
blasts, keratinocytes, DCs and Langerhans cells in the skin, but whether these cells participate 
in the global pathology of the disease remains unclear [10–12, 14, 21].
The appropriate interactions between Ags and immune system cells are essential to start an 
efficient adaptive immune response in secondary lymphoid tissues such as LNs. For most 
Ags—including pathogens—it is not well known how exactly they reach LNs and then the 
subcompartments within, for instance, the B cell follicles. Experimental evidence suggests 
that certain free Ags could reach LNs directly by lymph flow and then distribute by subcapsu‐
lar (SCS) and medullary sinus or by means of conduits inside [22–25]. These Ags could also be 
ferried to nodes by sentinel cells coming from peripheral tissues such as the skin or mucosae. 
Of note, these various paths of Ag transport are highly dependent on Ag size [22].
However, there is no information on how DENV reaches the DLNs after cutaneous infec‐
tion, where exactly DENV might be localized inside DLNs (if it does), and whether the first 
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contact between DENV and immune cells could influence subsequent immune responses, 
for instance, neutralizing or facilitating antibodies.
We aimed at assessing the natural in vivo route of DENV, from its entrance through the skin 
until its arrival and distribution inside regional DLN, as well as, its potential association with 
antigen presenting cells (APCs).
2. Materials and methods
2.1. Mice
Adult male BALB/c mice were used for all the experiments. Mice were fed ad libitum and 
housed in a specific pathogen‐free environment at the local animal facilities, UPEAL. The 
experimental procedures were approved by the ethical committee of the Center for Advanced 
Research, The National Polytechnic Institute, Cinvestav‐IPN. A group of mice was cutane‐
ously inoculated in the shaved inguinal region with a single dosage of 1 × 106 PFU of fluo‐
rescently labeled DENV serotype 2, another group with 5 µg of Alexa Fluor 555‐Ovalbumin 
(Life Technologies; Eugene, OR, USA) and the control group with sterile phosphate‐buffered 
saline (PBS) only. After 1, 3, 6, 12 and 24 hours post‐inoculation (hpi), small pieces of skin at 
the inoculation site and DLNs were extracted and processed either to perform flow cytometry 
or in situ fluorescence, as indicated.
2.2. Antibodies and reagents
The following primary antibodies were used: rat anti‐F4/80 (Cl:A3‐1), rat anti‐CD169 
(MOMA‐1), both were purchased from Serotec‐Bio‐Rad (Kidlington, UK); hamster anti‐CD11c 
(HL3), rat anti‐B220 (RA3‐6B2), rat anti‐Gr‐1 (RB6‐8C5), rat anti‐I‐A/I‐E (2G9), all purchased 
from BD Pharmingen (San Diego, CA, USA) and rat anti‐DEC‐205 (205yekta) was purchased 
from eBioscience (San Diego, CA, USA). Primary antibodies were used directly coupled to 
allophycocyanin, fluorescein isothiocyanate, PerCP/Cy5.5 or were detected by the follow‐
ing secondary reagents: donkey anti‐rat Alexa Fluor 488 purchased from Life Technologies 
(Eugene, OR, USA) and Cy5‐streptavidin and 4′,6‐diamino‐2‐fenilindol (DAPI) purchased 
from Invitrogen (San Francisco, CA, USA).
2.3. Obtaining dengue virus stock
We obtained DENV stock in vitro by infecting the insect cell line C6/36 (from Aedes albop‐
ictus larvae) with brain extracts of infected neonate mice. C6/36 cells were grown in mini‐
mum essential medium eagle (MEM) supplemented with 10% Fetal Bovine Serum (Gibco), 
Amphotericin B, Penicillin, Streptomycin, Pyruvate, Vitamins and l‐glutamine, at 34°C in 
75‐cm2 culture flask (Corning). Infection was performed when cells reached 95% conflu‐
ency. After 48 h post‐infection, cell supernatant containing DENV was collected and concen‐
trated with Amicon Centrifugal Filter Units (Merk Millipore, Co. Cork, IRL). Quantification 
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of infectious virions was performed by means of a plaque forming assay in Baby Hamster 
Kidney cell (BHK‐21) and reported as Plaque‐Forming Units (PFU)/ml.
2.4. Fluorescent labeling of dengue virus
For in vivo DENV tracking in tissues (skin and LNs), we labeled DENV with a strong red fluo‐
rescent dye (PKH‐26, Sigma). Briefly, DENV was mixed with PKH‐26 dye in the appropriate 
diluent and incubated for 5 min at room temperature. To stop the reaction, we added washing 
buffer (10% Fetal Bovine Serum in PBS). Because of the virus size, we applied ultrafiltration 
using centrifugal filter units and centrifuged at 4000 × g for 20 min at 4°C. The last step of 
washing was carried out only with cold sterile PBS.
2.5. Immunofluorescence of LNs and skin
DLN and skin samples were obtained after 1, 3, 6, 12 and 24 hpi from the different groups of 
experimental animals: PBS‐inoculated mice, mice injected with Ovalbumin (OVA) tagged with 
Alexa Fluor‐555 or mice inoculated with fluorescently labeled DENV. Tissues were embedded 
in optimal cutting temperature (OCT) compound Tissue Tek (Sakura FineTek, Torrance, CA, 
USA), frozen in liquid nitrogen and cut into 5 µm sections on a cryostat (Leica). Cryosections 
were put on poly‐l‐lysine‐coated glass slides and fixed with ethanol for 7 min at −20°C. To 
identify Mfs, we used F4/80 and CD169 antibodies, CD11c and DEC‐205 antibodies for DCs 
and B220 antibody for B lymphocytes; tissue sections were immunolabeled overnight at 4°C 
with the corresponding primary antibodies. After three washing steps, fluorescent secondary 
antibodies or streptavidin were incubated during 1 h or 15 min, respectively. Images were 
scanned with Leica TCS SP8 AOBS Confocal microscopy using objectives with 10× and 40× 
magnification and analyzed with Leica Software.
2.6. Flow cytometry of lymph node cell suspensions
DLNs were obtained 1, 3, 6, 12 and 24 h after animals were inoculated in the skin with either 
PBS as a control, or with fluorescently labeled DENV. The cell suspension obtained was blocked 
with Universal Blocker (BioGenex Laboratories, San Ramón, CA). Then, single‐cell suspension 
was incubated with anti‐CD11c, anti‐I‐A/I‐E, anti‐Gr‐1, anti‐F4/80, anti‐CD169, anti‐B220 and 
secondary antibodies for 25 min at 4°C in FACS buffer (BSA 1%, NaN3 0.01% in PBS) to iden‐tify APCs and finally fixed with paraformaldehyde 1% for FACS reading. Labeled cell suspen‐
sions were acquired with a BD LSR Fortessa III and analyzed with Flowjo X.0.6 for Windows 
(Ashland, OR).
2.7. Statistical analyses
We performed an ANOVA test for comparing groups using GraphPad Prism v6.0 Software, 
lines in bars or dots represent ± SEM (standard error of the mean). We considered 95% confi‐
dence intervals and significant difference when the P value was <0.05.
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3. Results
3.1. Upon cutaneous inoculation DENV is located in the deep dermis and therefore not 
associated with epidermal DEC‐205+ DCs
To assess the distribution of DENV in the skin upon cutaneous (intradermal) inoculation, we 
used immunocompetent mice and fluorescently labeled DENV. We assessed skin  cryosections 
after 1, 3, 6, 12 and 24 h post‐intradermal inoculation of DENV and, as a control we evalu‐
ated the distribution of fluorescently labeled OVA at 1 h and 12 hpi. DENV was readily found 
in the basement of the dermis at all the times evaluated and its presence decreased over 
time. Putative associations of DENV with epidermal DEC‐205+ DCs were not observed, likely 
because DENV was much deeper than the rather superficial epidermal DEC‐205+ cells. At 
24 hpi, the skin appears thicker than at early times suggesting recruitment of cells (Figure 1A). 
While no fluorescent signal was detected in skin of mice inoculated only with PBS (Figure 1A), 
fluorescent OVA was clearly seen in the dermis at 1 h but not at 12 hpi (Figure 1B).
3.2. Ovalbumin is found in the medullary sinus of the LNs at 1 h but not at 12 h  
post‐cutaneous inoculation
Ovalbumin has been used as model Ag in some experimental approaches to describe the 
distribution of molecules inside LNs. Because of its molecular size, OVA reaches LNs quickly. 
We used red fluorescent OVA as a control molecule and evaluated its distribution after 1 h 
Figure 1. Inoculation of fluorescently labeled DENV allows its identification in the skin of immune‐competent mice. 
Mice were cutaneously inoculated with red fluorescent DENV in the inguinal region and skin cryosections were 
analyzed after 1, 3, 6, 12 and 24 hpi by confocal microscopy. As controls, mice received either PBS or red fluorescent OVA. 
DEC‐205+ DCs (green) are localized mainly in the epidermal layer in all experimental conditions. (B) Red fluorescent 
OVA was in the dermis at 1 h but much less was seen at 12 hpi, whereas (A) red fluorescent DENV was located in the 
deep dermis from 1 hpi decreasing afterwards. In the skin of PBS‐inoculated mice, no red fluorescence was detected (left 
image in (A)). Nuclei were stained with DAPI (blue). Stratum corneum exhibits some autofluorescence at 3 h and 24 hpi 
(A) and 12 hpi (B). Bar scale = 300 µm. Images are representative of six skin sections per experimental group.
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and 12 hpi. At 1 hpi, OVA was found in the medullary sinus mainly associated with CD169+ 
Mfs and much less with F4/80+ Mfs (Figure 2A). At 12 hpi, only scarce red fluorescence was 
detected in F4/80+ cells (Figure 2B).
3.3. Cutaneous DENV reaches lymph node B follicles since 1 h post‐inoculation
To ascertain whether DENV was distributed in B cell follicles at early times post‐cutaneous 
inoculation, we obtained DLNs of mice after 1, 3, 6, 12 and 24 hpi. DLNs cryosections were 
labeled with B220 antibody to identify B lymphocytes. Red fluorescent DENV was clearly iden‐
tified in the paracortical areas, the SCS, the medullary sinus and in some B cell follicles (top pic‐
tures) at early time points. For a more detailed examination of B cell follicles, we used a higher 
magnification objective (bottom pictures) showing that at 1 hpi, small clusters of DENV mark 
were present inside follicles in apparent close association with B cells. At 3 hpi, very few asso‐
ciations were detected in follicles probably because most DENV fluorescence was by then seen 
at the medullary zone. In contrast, at 6 hpi, we observed some DENV mark inside B cell follicles 
and even in cells with macrophage‐like morphology and the red fluorescence apparently in 
the cytoplasm. At 12 h and 24 hpi, we did not detect fluorescent DENV signal in situ (Figure 3).
3.4. Inside lymph nodes DENV appears differentially associated with CD169+ and to 
F4/80+ macrophages in situ
Mfs are crucial for the clearance of pathogens and have been classified according to restricted 
markers and location inside LNs. Mfs located in the medullary sinus—where highly phago‐
cytic activity is carried out—are called medullary Mfs, whereas those delineating the floor 
Figure 2. Distribution of red fluorescent OVA in LNs after cutaneous inoculation. DLNs from mice cutaneously 
inoculated with red fluorescent OVA were harvested at (A) 1 hpi and (B) 12 hpi. CD169+ (top images) and F4/80+ (bottom 
images) Mfs are seen in green, whereas nuclei are seen in blue. Red fluorescent OVA is clearly observed in the medullary 
sinus of DLNs at 1 hpi, but not at 12 hpi. The distribution of OVA seems contained by the SCS Mfs but not by F4/80+ Mfs. 
Bar scale = 300 µm (left images) and 100 µm (right images). Images are representative of six LNs per experimental group.
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of SCS are called SCS Mfs. Medullary Mfs are either CD169+ or F4/80+, whereas SCS Mfs 
are CD169+ [26].
We assessed in situ in DLNs the potential involvement of CD169+ or/and F4/80+ Mfs in 
capturing DENV after 1, 3, 6, 12 and 24 h post‐cutaneous inoculation. Interestingly, since 
1 hpi, many CD169+ cells with seemingly cytoplasmic DENV were observed, mainly in 
SCS and medullary sinus. DENV was also found in paracotical areas in association with 
CD169‐ cells (Figure 4A). In contrast, at 1 hpi only few F4/80+ medullary Mfs were associated 
with DENV (Figure 4B). After 3 hpi, DENV was mostly restricted to medullary sinus and 
the CD169+ Mfs (Figure 4A). At this time point, DENV was poorly associated with F4/80+ 
Mfs. Interestingly, many F4/80‐ cells, most likely CD169+ Mfs, were observed with large 
amounts of DENV apparently in small phagocytic vesicles, as was observed at high mag‐
nification (Figure 4B). After 6 hpi, we still detected DENV signal mainly associated with 
CD169+ Mfs (Figure 4A). At the latest times evaluated (12 and 24 hpi), no red fluorescent 
signal was detected.
3.5. The CD11c+ DCs in regional lymph nodes are DENV+ from early times  
post‐cutaneous inoculation
DCs migrate from peripheral tissues such as the skin (and mucosae) to secondary lymphoid 
organs like LNs. Because DENV enters through the skin, it is highly likely that skin DCs might 
participate in delivering DENV into DLNs. We thus probed DLN cryosections with CD11c and 
DEC‐205 antibodies at 1, 3, 6, 12 and 24 h post‐cutaneous inoculation of red fluorescent DENV. 
At 1 hpi, we found DENV in close association with CD11c+ cells but not with DEC‐205+ cells in 
the DLN paracortex. At 3 hpi, we could not find DENV in the paracortex, neither associated with 
CD11c+ cells nor with DEC‐205+ cells; instead, red fluorescent DENV was restricted to medul‐
lary areas. At 6 hpi, DENV was associated with some CD11c+ cells, but not with DEC‐205+ cells. 
As mentioned before, DENV was not detected in regional LNs at 12 h nor at 24 hpi (Figure 5).
Figure 3. DENV and B cells in DLN cryosections of mice cutaneously inoculated with red fluorescent DENV. LNs 
cryosections of mice inoculated in the skin with red fluorescent DENV were probed with B220 antibody detected with 
green fluorescence. Analysis was performed by confocal microscopy at 1, 3, 6, 12 and 24 hpi. We found red fluorescent 
DENV from 1 h to 6 hpi in B cell follicles (green fluorescence), at 1 hpi DENV was mainly in perifollicular areas. Nuclei 
were stained with DAPI as observed in blue. As control, DLN sections from PBS‐inoculated mice were analyzed, and 
no red fluorescence was detected (left images). Scale bar = 300 µm (top images) and 100 µm (bottom images). Images are 
representative of six LNs per experimental group.
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3.6. Flow cytometry analysis of Ag presenting cells and DENV in DLNs after cutaneous 
inoculation
For a more quantitative assessment of APCs associated with DENV, we used DLN cell sus‐
pensions from mice inoculated at various times with fluorescent DENV in the skin. A very 
low proportion (0.06–0.17%) of B cells was positive for DENV at all time points evaluated 
(1 h‐24 hpi). This might be due to the very low number of Ag‐specific B cells (Figure 6A). 
CD169+ Mfs were also positive for DENV, with an apparent peak (0.83%) at 3 hpi, which cor‐
relates well with the medullary localization observed in situ (Figure 6B). Regarding F4/80+ 
Mfs, the proportion of positive cells varied from 0.3 to 0.57% along the experiment, with the 
maximum at 1 hpi (Figure 6C). DCs were identified as Gr‐1−, MHC‐II+ and CD11c+ cells and 
were the most abundant DENV+ population. The highest mean proportion (4%) of DENV+ 
Figure 4. DENV and (CD169+ or F4/80+) macrophages in regional LNs. DLNs from mice inoculated in the skin with PBS 
or red fluorescent DENV were collected at 1, 3, 6, 12 and 24 hpi, and cryosections were labeled to identify (A) CD169+ 
or (B) F4/80+ Mfs both in green. Nuclei were stained with DAPI as observed in blue. DLN sections were scanned by 
confocal microscopy. (A) DENV was distributed in SCS at 1 hpi (yellow color at the edge) and mainly in medullary 
sinuses apparently in the cytoplasm of CD169+ Mfs from 1 h to 6 hpi (white arrowheads, bottom images). (B) Very few 
associations of red‐fluorescent DENV with F4/80+ Mfs were found in the medullary zones. No red fluorescence was 
detected in PBS inoculated mice (left images). Bar scale = 300 µm [top images in (A) and (B)] and 100 µm [bottom images 
in (A) and (B)]. Images are representative of six LNs per experimental group.
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DCs was seen at 1 hpi decreasing afterwards to a minimum (0.85%) at 24 hpi (Figure 6D). 
We integrated all values in a graph (Figure 6E) to compare the percentages of all DENV+ 
APCs assessed. It seems that DCs are the main DENV+ cells, especially at early times post‐
inoculation, suggesting that either these cells are carrying DENV from skin to the nodes or are 
the main cells capturing the virus once DENV arrives into the nodes.
Figure 5. DENV and DCs in regional lymph nodes. Immune‐competent mice were intradermally inoculated with 
red fluorescent DENV, and DLNs were harvested at 1, 3, 6, 12 and 24 hpi. CD11c+ DCs were identified in light blue 
fluorescence, DEC‐205+ DCs in green, whereas nuclei are seen in dark blue. As described, DENV was detected from 
1 h to 6 hpi. At 1 hpi, red fluorescent DENV was located in the paracortical area and clearly associated with light blue 
CD11c+ DCs which then appear white due to merged colors (bottom image, yellow arrowheads indicate white color 
DCs). Red DENV was not associated with green DEC‐205+ DCs. Cryosections of PBS inoculated mice did not show red 
fluorescence (left images). Bar scale = 300 µm (top images) and 100 µm (bottom images). Images are representative of six 
LNs per experimental group.
Figure 6. Flow cytometry assessment of DENV+ cells in regional LNs. Cell suspensions of DLNs harvested 1, 3, 6, 12 and 
24 h after inoculating red fluorescent DENV were labeled for B cells (B220), Mfs (CD169 and F4/80) and DCs (CD11c). 
Red fluorescence co‐staining was used to determine the percentage of each DENV+ cell population. (A) A very low 
proportion of DENV+ B cells was observed from 1 h to 24 hpi. (B) The amount of DENV+ CD169+ Mfs was higher 
than (C) DENV+ F4/80+ Mfs from 1 h to 24 hpi. (D) The proportion of DENV+ CD11c+ DCs was higher than the other 
populations, reaching a maximum at 1 hpi declining afterwards. Graph in (E) shows the integrated results of all cell 
subsets during the kinetic follow up. Bars in graphs represent the median ± SEM of percentages, and ANOVA analysis 
was performed, considering *p > 0.05, **p > 0.01 and ****p > 0.0001.




While many cells in the skin can make contact with DENV during mosquito biting (a topic under 
intense investigation recently), very few cells will have the ability to capture DENV and to ferry 
it into lymphatic vessels and from there to secondary lymphoid tissues. Cutaneous DCs can 
uptake DENV and migrate into DLNs to the DC area, where the most likely cells to make the 
first immune contacts with DENV+ DCs will be T lymphocytes [27]. Some B cells could also 
interact with DENV Ags in this area and follow either an extrafollicular response or get into a GC 
reaction [28, 29]. Still another possibility inside LNs is the display of DENV Ags by Mfs, either 
in the SCS or deeper in the paracortical and medullary zones [30]. Thus, LNs are crucial organs 
to establish effective adaptive immune responses. For this, the efficient interaction between 
immune cells and Ags is needed. The ensuing events upon arrival of Ags inside LNs might 
depend on how these Ags are getting there, whether the Ag is arriving alone through the lymph 
flow or is carried by different cells which could be important to the type of the immune response 
that follows. Herein, we discuss some of these possibilities regarding DENV infection in vivo.
DENV enters the human host through the skin while mosquitoes feed. After locating a suit‐
able host, an infected mosquito probes throughout the dermis introducing the proboscis and 
is during this process that the salivary glands release the virus [31]. Conceivably, viral parti‐
cles are likely to interact first with the various cells of epidermal and dermal layers. However, 
both the very early stages of DENV infection and the initial local encounters between DENV 
and elements of the local immune system in situ remain largely unexplored.
By infecting ex vivo healthy human skin explants from non‐cadaveric samples, our group 
demonstrated DENV‐infected cutaneous DCs [11]. We have also identified that human kera‐
tinocytes and dermal fibroblasts are permissive to DENV infection and that they respond 
by secreting a wide variety of soluble mediators that contribute to induce an immune‐acti‐
vated microenvironment and an antiviral state [10, 11, 32]. Now, upon cutaneous inoculation 
of fluorescently labeled DENV into immune‐competent mice, we evaluated the presence of 
DENV as well as its localization in both the skin and the DLNs. We did a kinetic follow‐up by 
in situ immunofluorescence as well as in cell suspensions by FACS. In the skin, we found the 
virus localized mostly through the dermis at 1 h post‐inoculation, afterwards DENV was dis‐
tributed deep in the skin. To the best of our knowledge, this is the first time that fluorescently 
labeled DENV is used to assess its distribution in vivo.
Some reports in humans and mice have shown DENV proteins inside LNs, both at the periph‐
ery and inside B cell follicles [13, 16, 33–35]. Where the virus is located inside DLNs could 
influence the first contact with cells from the immune system and the subsequent immune 
response. However, how DENV reaches the DLNs after cutaneous infection has not been 
explored in vivo. Using the vesicular stomatitis virus, researchers have investigated how viral 
particles that enter through peripheral tissues are handled within DLNs, identifying a popu‐
lation of Mfs on the floor of the SCS and in the medulla of LNs that capture viral particles 
within minutes after subcutaneous injection [30]. Similar to other Ags delivered through 
the skin, the Bluetongue Virus is transported rapidly through the lymph to the DLNs in its 
 natural host the sheep [36].
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After 1 h of skin inoculation and once in DLNs, we found DENV associated with CD169+ Mfs 
from the subcapsular and medullary sinus and with CD11c+ DCs in the paracortical area. The 
association with these two cell types was seen especially at early times (1–6 h) after cutane‐
ous inoculation. The rapid localization of DENV in the SCS of the DLNs is consistent with 
delivery of putative cell‐free virus through the lymphatic fluid, besides that DCs might be 
also carrying the virus [36]. In the immune‐deficient murine model (AG129 mice), it has been 
shown that Mfs from the SCS are important controlling the spreading of DENV. These SCS 
Mfs contained NS1 protein, likely implying that they are trapping DENV Ags or are being 
actually infected [37]. In these same immune‐deficient mice, after intra‐footpad inoculation, 
it was shown that DENV initially targets Mfs of the DLN [38]. As SIGN‐R1, the murine homo‐
log of human DC‐SIGN is highly expressed on SCS Mfs [39], it is likely that DENV is infecting 
these Mfs in the DLN. Indeed, DC‐SIGN is one of the molecules used by DENV to enter host 
cells [40].
After the SCS Mfs trap DENV, these cells could translocate surface‐bound viral particles 
across the SCS floor and make DENV Ags available to other cells, for instance, migrating B 
cells in the underlying follicles. It seems that these Mfs from the SCS act as vigilants against 
many different pathogens and are able to discriminate between lymph‐borne viruses and 
other particles of similar size [30]. CD169+ Mfs in LNs could capture lymph‐borne viruses 
preventing their systemic dissemination and could guide captured virions across the SCS 
floor for the efficient activation of follicular B cells [30, 37].
In addition to this, DENV associated with DCs highly likely implies that DENV is transported 
from the skin to the DLNs by DCs. We and others have found DENV‐infected cutaneous DCs 
in human cadaveric and non‐cadaveric healthy skin explants infected ex vivo [11, 14, 21]. Thus, 
DENV might be reaching DLNs also through cutaneous DCs. Also, migratory DENV‐infected 
DCs have been found in the skin DLNs of mice lacking IFN‐α/β receptor (IFNAR−/− mice) 
infected through the skin, suggesting that dermal DCs might be ferrying DENV to regional 
nodes and likely triggering the adaptive immune response [14].
DCs are specialized sentinel cells that uptake Ags at peripheral tissues and travel to DLNs fer‐
rying Ags to paracortical areas, where B cells migrating toward follicles are likely to encoun‐
ter these Ags [23, 27, 41]. A hallmark of specific B lymphocyte activation is BCR‐mediated 
capturing/acquisition of Ags. This will facilitate the subsequent Ag presentation from B cells 
to T cells in order to develop efficient T cell‐dependent antibody responses [42]. DCs may 
provide B cells with broader access to Ags, particularly those of large sizes or associated with 
particulate materials. Lastly, through Ag presentation to T cells, DCs could subserve func‐
tions such as cellular platforms facilitating activation, colocalization and mutual communica‐
tion of rare Ag‐specific T and B cells, whose interaction may ultimately lead to optimal T and 
B cell responses [41].
Tracking in vivo fluorescently labeled DENV from the skin permitted us to know the rapid 
(1 hpi) localization of DENV in subcapsular and medullary Mfs of DLNs, its association with 
CD11c+ DCs in the T:B border and the presence of DENV inside B cell follicles. All these 
events make highly plausible that Ag‐specific B cells would be recognizing DENV and makes 
feasible that they would be receiving T cell help, these cellular interactions are needed to lead 
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to full antibody responses. To this respect, it is worth mentioning that antibody responses to 
DENV need very careful examination; ideally, these responses should be neutralizing [43, 44]. 
However, the potentially detrimental impact of non‐neutralizing antibodies enhancing the 
infection in vivo is only beginning to be elucidated, not only in heterotypic reinfections with 
DENV but also in infections with other flaviviruses such as Zika [44–48].
Altogether, these data suggest that after being inoculated into skin, DENV is reaching the 
regional lymph nodes in at least two ways, through the lymph fluids but also being carried by 
cells. Travelling with DENV from the skin to the regional LNs will allow us to better understand 
how the immune system is being alerted or affected and which might be the cells responding 
at each stage. We believe that it is important to decipher the in vivo biology of these cellular 
responses to DENV entrance, not only for making better models to study early interactions 
among DENV, skin‐resident and LN cells but also to better understand the pathology of DENV.
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